研飞ivySCI (青藤学术）

Seminars in Thrombosis and Hemostasis

短名	Semin Thromb Hemost
Journal Impact	3.72
国际分区	PERIPHERAL VASCULAR DISEASE(Q1)
期刊索引	SCI Q1中科院 2 区

ISSN	0094-6176, 1098-9064
h-index	112
国内分区	医学(2区)医学血液学(2区)医学外周血管病(2区)

SEMINARS IN THROMBOSIS AND HEMOSTASIS 是一本主题驱动的评论期刊，重点关注与止血和血栓性疾病相关的所有问题。作为该领域首屈一指的评论期刊之一，SEMINARS IN THROMBOSIS AND HEMOSTASIS 是临床和实验室诊断和治疗干预方面重要进展的综合论坛。该杂志还发表同行评审的原始研究论文。研讨会为当今的关键问题提供了知情的观点，包括血友病 A 和 B、血栓形成倾向、基因治疗、静脉和动脉血栓形成、血管性血友病、血管疾病和血栓栓塞性疾病。注意是该杂志还关注药物的最新发展以及治疗和当前的管理技术。该杂志还经常出版赞助的增刊，以进一步突出该领域的新兴趋势。

期刊主页投稿网址

涉及主题	医学内科学生物心理学外科精神科化学免疫学生物化学遗传学病理血小板重症监护医学血栓形成心脏病学物理
出版信息	出版商: Thieme Medical Publishers, Inc.，出版周期: Bimonthly，期刊类型: journal
基本数据	创刊年份: 1974，原创研究文献占比: 76.70%，自引率:22.20%， Gold OA占比: 5.95%
平均审稿周期	网友分享经验：较慢,6-12周
平均录用比例	网友分享经验：一般

期刊引文格式

这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。

专利引用格式

Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps

2024-9-17

Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis)

2024-8-30

Role of Platelets and Their Interaction with Immune Cells in Venous Thromboembolism

2024-8-30

Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency

2024-8-29

Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII

2024-8-29

Clinical, Laboratory Aspects and Management of Factor X Deficiency

2024-8-29

Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality

2024-8-27

Platelet-Type von Willebrand Disease: Complex Pathophysiology and Insights on Novel Therapeutic and Diagnostic Strategies

2024-8-27

Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk

2024-8-27

Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management

2024-8-27

Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency

2024-8-27

Hereditary Thrombophilia: A Case of Subacute Pulmonary Embolism in a 68-Year-Old Female with a Mutation in the PROC Gene

2024-8-16

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers—for the External Quality Assurance in Thrombosis and Haemostasis Group

2024-8-16

Catastrophic Thrombosis: A Narrative Review

2024-8-16

Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders

2024-8-16

Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer

2024-7-24

Heparin and Posttraumatic Stress Disorder

2024-7-24

Antiphospholipid Antibodies in Mental Disorders

2024-7-24

The Impact of Emotional Responses on Female Reproduction: Fibrinolysis in the Spotlight

2024-7-19

Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part 3

2024-7-19

New STH 2023 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics

2024-7-19

Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans

2024-7-19

Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines

2024-7-1

Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis

2024-7-1

Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review

2024-7-1

2023 Eberhard F. Mammen Award Announcements: Part II – Young Investigator Awards

2024-7-1

Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review

2024-6-27

Stress-Induced Hypercoagulability: Insights from Epidemiological and Mechanistic Studies, and Clinical Integration

2024-6-24

Hemostasis Testing in the Emergency Department: A Narrative Review

2024-6-19

Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?

2024-6-18

Patient Perspective on Disease Burden and Gene Therapy for Hemophilia A and B: The “Haemvolution for Patients” Italian Survey

2024-6-18

Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies

2024-6-18

Platelet Pathophysiology: Unexpected New Research Directions

2024-6-18

Seminars in Thrombosis and Hemostasis

2024-6-12

Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents

2024-6-12

Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice

2024-6-12

Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives

2024-5-31

Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice

2024-5-29

Contact Activation: Where Thrombosis and Hemostasis Meet on a Foreign Surface, Plus a Mini-editorial Compilation (“Part XVI”)

2024-5-17

Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation

2024-5-11

Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes

2024-5-11

The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice

2024-5-11

Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays

2024-5-11

Thrombophilia Screening: Not So Straightforward

2024-5-11

Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis

2024-5-11

Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure

2024-5-11

帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理

投稿经验分享

分享我的经验，帮你走得更远

Seminars in Thrombosis and Hemostasis

期刊引文格式

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

学位论文引用格式

网页引用格式

专利引用格式

最新文章

Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps

Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis)

Role of Platelets and Their Interaction with Immune Cells in Venous Thromboembolism

Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency

Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII

Clinical, Laboratory Aspects and Management of Factor X Deficiency

Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality

Platelet-Type von Willebrand Disease: Complex Pathophysiology and Insights on Novel Therapeutic and Diagnostic Strategies

Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk

Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management

Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency

Hereditary Thrombophilia: A Case of Subacute Pulmonary Embolism in a 68-Year-Old Female with a Mutation in the PROC Gene

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers—for the External Quality Assurance in Thrombosis and Haemostasis Group

Catastrophic Thrombosis: A Narrative Review

Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders

Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer

Heparin and Posttraumatic Stress Disorder

Antiphospholipid Antibodies in Mental Disorders

The Impact of Emotional Responses on Female Reproduction: Fibrinolysis in the Spotlight

Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part 3

New STH 2023 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics

Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans

Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines

Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis

Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review

2023 Eberhard F. Mammen Award Announcements: Part II – Young Investigator Awards

Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review

Stress-Induced Hypercoagulability: Insights from Epidemiological and Mechanistic Studies, and Clinical Integration

Hemostasis Testing in the Emergency Department: A Narrative Review

Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?

Patient Perspective on Disease Burden and Gene Therapy for Hemophilia A and B: The “Haemvolution for Patients” Italian Survey

Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies

Platelet Pathophysiology: Unexpected New Research Directions

Seminars in Thrombosis and Hemostasis

Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents

Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice

Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives

Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice

Contact Activation: Where Thrombosis and Hemostasis Meet on a Foreign Surface, Plus a Mini-editorial Compilation (“Part XVI”)

Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation

Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes

The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice

Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays

Thrombophilia Screening: Not So Straightforward

Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis

Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure

帮你贴心管理全部的文献.css-5myebc{font-size:14px;font-weight:var(--chakra-fontWeights-normal);margin-top:var(--chakra-space-1);margin-bottom:var(--chakra-space-1);}研飞ivySCI，高效的论文管理

帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理